The clinical effect of an electric massage chair on chemotherapy-induced nausea and vomiting in cancer patients: randomized phase II cross-over trial
- Conditions
- Neoplasms
- Registration Number
- KCT0008200
- Lead Sponsor
- Korea University Anam Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 68
20 years old or older
-Patients with histologically confirmed solid tumors
-Patients receiving chemotherapy for the first time in their lives
-Patients who are planned to receive HEC/MEC as defined in the NCCN guideline 2019-2020
-ECOG PS 0-2 - defined as having appropriate cardiac and renal function as follows:
a. Hemoglobin = 8.0 g/dL
b. Absolute neutrophil count = 1.0 x 10^9/L
c. Platelet count = 75 x 10^9/L
d. Serum bilirubin = 1.5 x ULN
e. AST/ALT = 2.5 x ULN
f. Creatinine clearance calculated by the Cockcroft-Gault formula > 50 mL/min
-Patients with disseminated/extensive bone metastasis
-Patients with serious musculoskeletal diseases or peripheral vascular diseases as determined by the investigator
-Patients receiving anticoagulants or antiplatelet drugs
-Patients currently using a massager at home
-Patients who have undergone major surgery or experienced serious trauma within 2 weeks prior to the study
-Participants who use medications that may pose a risk to the participant or interfere with study results, or have medical/psychiatric/social disorders
-Patients with medical conditions that may increase the risk or interfere with the interpretation of study results according to the investigator's judgement or abnormal laboratory test results in the testing room.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method INVR
- Secondary Outcome Measures
Name Time Method complete response rate;EORTC-QLQ-C30